Drugwatch

Drugwatch collaborates with healthcare professionals, legal specialists, patients, and advocates to deliver reliable and up-to-date information on prescription drug side effects, complications from medical devices, and associated legal matters. Our dedicated team brings years of expertise in medical and legal research and is committed to supporting individuals affected by corporate negligence. With Drugwatch, users can access essential information to make informed decisions about their health care, share their personal experiences with drugs and devices, and connect with a knowledgeable national law firm for assistance.

Local

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#227221

United States

#69596

Health/Pharmacy

#136

Traffic sources

Monthly visitors

Articles

Teen Still Deals With NEC Issues After Drinking Formula as a Baby Sixteen Years Ago

3 weeks ago | drugwatch.com | Michelle Llamas |Renee Deveney

At first glance, Addison seems like a normal teenage girl. She’s cheerful and all smiles. But underneath her happy demeanor, she’s still dealing with the complications of necrotizing enterocolitis (NEC), a gastrointestinal condition that primarily impacts preterm infants. “Sometimes, I’m just like, I wish I really wasn’t sick because it sucks,” Addison said as she sat next to her mom, Cassidy.
Colorado Mom Warns Others About Paragard IUD

1 month ago | drugwatch.com | Michelle Llamas |Renee Deveney

When Colorado resident and mom S.F., who asked to use her initials for her privacy, talked to her doctor about having her Paragard IUD removed, she treated it like any other routine procedure. She had no idea she should be worried. That routine removal turned into an emotional nightmare when the IUD broke inside her, leaving a piece of the device in her body. S.F. isn’t alone. At least 2,965 women have filed Paragard IUD lawsuits centralized in The Northern District Court of Georgia.
Why Women Are Filing BioZorb Lawsuits: A Q&A With Attorney Marlene Goldenberg

1 month ago | drugwatch.com | Renee Deveney |Michelle Llamas

BioZorb lawsuits first began trickling into the United States District Court for the District of Massachusetts toward the end of 2022. After device maker Hologic, Inc. pulled more than 91,000 devices off the market in October 2024, the litigation has gotten more attention. The BioZorb Marker and BioZorb LP Marker are implantable radiographic markers used to mark soft tissue, most commonly breast tissue.
What You Should Know About Social Media Harm Lawsuits: Q&A With Attorney Brendan Smith

1 month ago | drugwatch.com | Renee Deveney |Michelle Llamas

In 2024, Surgeon General Dr. Vivek Murthy called on Congress to add a warning label to social media platforms, saying “social media is associated with significant mental health harms for adolescents.” As the concern over social media’s negative impact on children, teens and young adults grows, people have begun suing social media companies Meta, Snap, ByteDance and Google. Claims state that the companies designed their social media apps to be addictive and target children.
Q&A with Attorney Brendan Smith

1 month ago | drugwatch.com | Renee Deveney |Michelle Llamas

Parents of pre-term infants diagnosed with necrotizing enterocolitis (NEC) are filing lawsuits against baby formula makers Abbott and Mead Johnson. The lawsuits allege that the companies failed to warn consumers about the increased risk of NEC among premature babies fed certain cow’s milk baby formulas. NEC is a disease that causes inflammation of the bowel. The inflammation can lead to bacterial invasion, which causes cell damage and tissue death within the colon and intestine.
Why Are People Filing Bard PowerPort Lawsuits: Q&A With Attorney Brendan Smith

1 month ago | drugwatch.com | Renee Deveney |Michelle Llamas

Lawsuits against Bard (now Becton, Dickinson and Company) claim that the company failed to warn the public about serious complications related to their PowerPort implantable catheter. As of March 2025, the Bard PowerPort MDL includes about 1,112 active pending lawsuits in Arizona. The Bard PowerPort catheter is an implantable medical device designed to provide central venous access for treatments like chemotherapy or long-term medication. It also delivers intravenous fluids and nutrition.
BioZorb Lawsuit | 2025

1 month ago | drugwatch.com | Michelle Llamas |Renee Deveney

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations. Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified.
What J&J’s Now $9 Billion Settlement Offer Means for Talcum Powder Lawsuits

Sep 6, 2024 | drugwatch.com | Christian Simmons |Emily Miller

Johnson & Johnson’s proposed settlement for its ongoing baby powder litigation has increased as it nears finalization. The pharmaceutical giant has tacked an additional $1.1 billion onto the $6.48 billion ovarian cancer settlement that it initially proposed in May. If approved, Johnson & Johnson would pay out the settlement over 25 years, resulting in an estimated total of $9 billion paid. Support for the settlement has continued to grow among plaintiffs.
Children’s Social Media Use a Major Stressor for Parents, Surgeon General Advisory Says

Sep 3, 2024 | drugwatch.com | Christian Simmons |Emily Miller

The U.S. Surgeon General has released a new advisory on the mental health and well-being of parents, with the impact of social media on their children front and center. The advisory, which calls attention to parental stress, included information on emerging concerns that are playing an increased role in parenting. “There are new stressors that previous generations didn’t have to consider,” Surgeon General Vivek Murthy said in the advisory foreword.
Depo-Provera Side Effects

Aug 28, 2024 | drugwatch.com | Michelle Llamas |Emily Miller

Fact-Checked Editors carefully fact-check all Drugwatch.com content for accuracy and quality. Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines. We only gather information from credible sources.